Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Active and Placebo-controlled Study to Investigate the Safety and Efficacy of Ligelizumab (QGE031) in the Treatment of Chronic Spontaneous Urticaria (CSU) in Adolescents and Adults Inadequately Controlled With H1-antihistamines
INTERVENTIONAL
Inicio: 17 de oct de 2018
ID: NCT03580369
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of ABSSSI: REVIVE-2
INTERVENTIONAL
Inicio: 1 de nov de 2015
ID: NCT02607618
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-label Trial to Compare the Efficacy, Safety and Tolerability of DRV/Rtv (800mg/100mg) q.d Versus DRV/Rtv (600mg/100mg) b.i.d in Early Treatment-experienced HIV-1 Infected Subjects
INTERVENTIONAL
Inicio: 1 de oct de 2007
ID: NCT00524368
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE)
INTERVENTIONAL
Inicio: 1 de mar de 2018
ID: NCT03312907
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of 6-Day Oral TR-701 Free Acid and 10-Day Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
INTERVENTIONAL
Inicio: 15 de ago de 2010
ID: NCT01170221
Completado
Fase 2
ClinicalTrials.gov
A Pilot, Proof of Concept Trial to Prove Ivermectin Efficacy in the Reduction of SARS-CoV-2 Replication at Early Stages of COVID-19
INTERVENTIONAL
Inicio: 18 de may de 2020
ID: NCT04381884
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Adult Hospitalized Subjects With CAP Including COVID-19 Pneumonia.
INTERVENTIONAL
Inicio: 22 de dic de 2022
ID: NCT05531149
Reclutando
Fase 3
ClinicalTrials.gov
A Phase IIIB, Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition
INTERVENTIONAL
Inicio: 14 de may de 2024
ID: NCT06134362
Terminado
Fase 2
ClinicalTrials.gov
A Phase IIb Randomized, Controlled, Partially Blinded Clinical Trial to Investigate Safety, Efficacy and Dose-response of BMS-986001 in Treatment-naive HIV-1-infected Subjects, Followed by an Open-label Period on the Recommended Dose
INTERVENTIONAL
Inicio: 1 de feb de 2011
ID: NCT01489046
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared With Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
INTERVENTIONAL
Inicio: 1 de ene de 2012
ID: NCT01492426
Completado
ClinicalTrials.gov
Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina
OBSERVATIONAL
Inicio: 5 de ene de 2021
ID: NCT04738435
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Phase IIa Study in Asthma Patients Comparing the Efficacy and Safety of Once Daily Inhaled Interferon Beta-1a to Placebo, Administered for 14 Days After the Onset of Symptoms of an Upper Respiratory Tract Infection for the Prevention of Severe Exacerbations
INTERVENTIONAL
Inicio: 21 de jul de 2015
ID: NCT02491684
Completado
ClinicalTrials.gov
Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus: a Dilemma
OBSERVATIONAL
Inicio: 8 de oct de 2020
ID: NCT04609774
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection
INTERVENTIONAL
Inicio: 21 de jul de 2010
ID: NCT01069900
Completado
ClinicalTrials.gov
A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatitis C
OBSERVATIONAL
Inicio: 7 de feb de 2012
ID: NCT01492504
Terminado
Fase 2
ClinicalTrials.gov
A Phase II, Multicenter, Randomized, Open-label, Active Controlled Study to Evaluate the Safety and Efficacy of Micafungin Salvage Mono-therapy Versus Active Control Intravenous Salvage Mono-therapy in Patients With Invasive Aspergillosis
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00376337
Terminado
Fase 2
ClinicalTrials.gov
A Phase IIb, Randomized (Stratified), Double-Blind (Sponsor Open), Parallel-Group, Placebo-Controlled, Dose-Finding Study of Nemiralisib (GSK2269557) Added to Standard of Care (SoC) Versus SoC Alone in Participants Diagnosed With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 28 de nov de 2017
ID: NCT03345407
Terminado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01110382
Retirado
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Adult Subjects Infected With Human Metapneumovirus
INTERVENTIONAL
Inicio: 5 de nov de 2018
ID: NCT03502694
Completado
ClinicalTrials.gov
An Exploratory Study of the Effect of the Atazanavir (ATV) I50L Mutation on Subsequent Treatment Response
OBSERVATIONAL
Inicio: 1 de nov de 2004
ID: NCT00096746
Anterior
1
...
38
39
40
...
434
Siguiente
Filtros